Pacifica Capital Investments’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.3M Sell
464,803
-430
-0.1% -$13.6K 4.54% 8
2026
Q1
$14.6M Sell
465,233
-10,000
-2% -$315K 4.99% 7
2025
Q4
$14M Sell
475,233
-491
-0.1% -$13.6K 3.81% 6
2025
Q3
$12M Sell
475,724
-534
-0.1% -$13K 3.26% 6
2025
Q2
$11.4M Buy
476,258
+20,469
+4% +$475K 3.36% 6
2025
Q1
$10.4M Buy
455,789
+262,484
+136% +$6.33M 3.71% 6
2024
Q4
$4.89M Buy
+193,305
New +$4.9M 1.58% 10

Other funds holding RTO

Pacifica Capital Investments's RTO Position: Q2 2026 in Review

Pacifica Capital Investments reduced its Rentokil (RTO) stake by 0.09% in Q2 2026, selling an estimated $13.6K and leaving 464,803 shares worth $13.3M. The position accounts for 4.54% of the portfolio, ranked #8.

Pacifica Capital Investments first reported a position in RTO in Q4 2024 and has held it in 7 quarters since. The position peaked at $14.6M in Q1 2026. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Pacifica Capital Investments held 464,803 shares of Rentokil worth $13.3M as of Q2 2026.
  • Pacifica Capital Investments sold 430 Rentokil shares in Q2 2026, an estimated $13.6K.
  • Rentokil made up 4.54% of Pacifica Capital Investments's portfolio in Q2 2026, its #8 holding.
  • Pacifica Capital Investments first reported a position in Rentokil in Q4 2024 and has held it in 7 quarters since.
  • Pacifica Capital Investments's Rentokil position peaked at $14.6M in Q1 2026.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Pacifica Capital Investments's 13F filing for Q2 2026, filed 12 Aug 2026.